Market Overview:
The global urethral bulking agents market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of urinary incontinence, rising geriatric population, and technological advancements in urethral bulking agents. Based on type, the global urethral bulking agents market is segmented into coaptite urethral, water-soluble gel, and other types. Coaptite Urethral held a dominant share in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to its high efficacy and safety profile as compared to other types of urethral bulking agents available in the market.
Product Definition:
Urethral bulking agents are used to treat urinary incontinence.
Coaptite Urethral:
Coaptite urethral is a new type of bulking agent that has recently been developed by the research department at GlaxoSmithKline. Coaptite Urethral is used as an external measure to treat conditions such as urinary stress and urge incontinence associated with benign prostatic hyperplasia (BPH). Coaptite Urethral has also shown efficacy in reducing the risk of bladder cancer.
Water-soluble Gel:
Water-soluble gels are a type of urethral bulking agent used in the treatment of Erectile Dysfunction (ED) and Prostatic Hyperplasia (PH). ED is caused by decreased blood flow in the corpora cavernosa. The use of water-soluble gel allows an increase in the amount of blood that flows through the penis, thereby improving erections.
Application Insights:
Based on the application, the global market is segmented into hospital, clinic and others. The other applications include post-surgical care and urology ICU. The hospital segment dominated the overall market in terms of revenue in 2017 owing to a high prevalence of urinary disorders that require bladder management techniques for treatment. According to a study published by NCBI, around 8 out of 10 men will experience some degree of stress or urgency during sleep hours at least once in their lifetime. Thus, increasing number of hospitals worldwide is expected to contribute towards growth over next few years.
The Clinic segment was estimated as largest sub-segment owing to growing awareness about better management options for patients with incontinence and pelvic pain problems caused due to insufficient urine flow through the penis.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing cases of bladder obstruction, urological problems, and other urinary disorders. In addition, rising awareness about urethral bulking agents among patients is expected to drive the product demand over the forecast period. Moreover, a well-established healthcare infrastructure and high disposable income are some other factors contributing toward regional growth.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to improving economic conditions in emerging countries such as India and China along with growing medical tourism industry in these nations which will result into an increase in urethral procedures/hospital visits over time.
Growth Factors:
- Increasing incidence of urinary incontinence: The global urethral bulking agents market is expected to grow at a CAGR of 5.5% during the forecast period due to the increasing incidence of urinary incontinence, which is a major factor driving the demand for urethral bulking agents. Urinary incontinence is a condition in which there is an involuntary loss of urine, and it affects millions of people across the world. This condition can be caused by various factors such as age, pregnancy, childbirth, obesity, and menopause.
- Growing awareness about available treatment options: There has been an increase in awareness about available treatment options for urinary incontinence in recent years owing to growing public awareness campaigns by various healthcare organizations and government agencies worldwide. This is expected to drive demand for urethral bulking agents over the forecast period.
- Technological advancements in urethral bulking agent products: The global urethral bulking agents market has been witnessing significant technological advancements over the past few years with manufacturers introducing new products that are more effective and have fewer side effects than older products available in the market. This trend is likely to continue over the forecast period, resulting in increased adoption of these products among patients suffering from urinary incontinence disorders..
Scope Of The Report
Report Attributes
Report Details
Report Title
Urethral Bulking Agents Market Research Report
By Type
Coaptite Urethral, Water-soluble Gel, Other
By Application
Hospital, Clinic, Other
By Companies
Cogentix Medical, Boston Scientific, Axonics, Cigna, Laborie, Coloplast, Cogentix Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Urethral Bulking Agents Market Report Segments:
The global Urethral Bulking Agents market is segmented on the basis of:
Types
Coaptite Urethral, Water-soluble Gel, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cogentix Medical
- Boston Scientific
- Axonics
- Cigna
- Laborie
- Coloplast
- Cogentix Medical
Highlights of The Urethral Bulking Agents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Coaptite Urethral
- Water-soluble Gel
- Other
- By Application:
- Hospital
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Urethral Bulking Agents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Urethral bulking agents are substances that are used to increase the size of the urethra. This can be done by increasing the amount of fluid in the urethra, or by increasing the number of cells in the lining of the urethra.
Some of the key players operating in the urethral bulking agents market are Cogentix Medical, Boston Scientific, Axonics, Cigna, Laborie, Coloplast, Cogentix Medical.
The urethral bulking agents market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Urethral Bulking Agents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Urethral Bulking Agents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Urethral Bulking Agents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Urethral Bulking Agents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Urethral Bulking Agents Market Size & Forecast, 2018-2028
4.5.1 Urethral Bulking Agents Market Size and Y-o-Y Growth
4.5.2 Urethral Bulking Agents Market Absolute $ Opportunity
Chapter 5 Global Urethral Bulking Agents Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Urethral Bulking Agents Market Size Forecast by Type
5.2.1 Coaptite Urethral
5.2.2 Water-soluble Gel
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Urethral Bulking Agents Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Urethral Bulking Agents Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Urethral Bulking Agents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Urethral Bulking Agents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Urethral Bulking Agents Analysis and Forecast
9.1 Introduction
9.2 North America Urethral Bulking Agents Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Urethral Bulking Agents Market Size Forecast by Type
9.6.1 Coaptite Urethral
9.6.2 Water-soluble Gel
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Urethral Bulking Agents Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Urethral Bulking Agents Analysis and Forecast
10.1 Introduction
10.2 Europe Urethral Bulking Agents Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Urethral Bulking Agents Market Size Forecast by Type
10.6.1 Coaptite Urethral
10.6.2 Water-soluble Gel
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Urethral Bulking Agents Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Urethral Bulking Agents Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Urethral Bulking Agents Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Urethral Bulking Agents Market Size Forecast by Type
11.6.1 Coaptite Urethral
11.6.2 Water-soluble Gel
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Urethral Bulking Agents Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Urethral Bulking Agents Analysis and Forecast
12.1 Introduction
12.2 Latin America Urethral Bulking Agents Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Urethral Bulking Agents Market Size Forecast by Type
12.6.1 Coaptite Urethral
12.6.2 Water-soluble Gel
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Urethral Bulking Agents Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Urethral Bulking Agents Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Urethral Bulking Agents Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Urethral Bulking Agents Market Size Forecast by Type
13.6.1 Coaptite Urethral
13.6.2 Water-soluble Gel
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Urethral Bulking Agents Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Urethral Bulking Agents Market: Competitive Dashboard
14.2 Global Urethral Bulking Agents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cogentix Medical
14.3.2 Boston Scientific
14.3.3 Axonics
14.3.4 Cigna
14.3.5 Laborie
14.3.6 Coloplast
14.3.7 Cogentix Medical
